• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    More On HIK.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Hikma Pharmaceuticals plc (HIK.L)

    -LSE
    2,142.00 Down 7.00(0.33%) May 22, 11:35AM EDT
    Add to Portfolio
    Prev Close:2,149.00
    Open:2,149.00
    Bid:2,141.00
    Ask:2,143.00
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:2,135.00 - 2,158.00
    52wk Range:1,579.00 - 2,617.00
    Volume:241,594
    Avg Vol (3m):509,079
    Market Cap:4.26B
    P/E (ttm):1,541.01
    EPS (ttm):1.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in GBp.

    Key Statistics

    Forward P/E (1 yr):12.98
    P/S (ttm):286.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :1.40
    Quarterly EPS Est (Jun-15) :N/A
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):1.15

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms in the Middle East and North Africa, the United States, Europe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback